John Hancock Multifactor Healthcare ETF is a ETF series of John Hancock Exchange-Traded Fund Trust (series S000050957). Net assets $41.9M as of 2022-07-31. Index fund.
Showing 15 of 120 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Johnson and Johnson | — | $2.7M | 636.23% |
| Unitedhealth Group Incorporated | — | $2.5M | 604.77% |
| Pfizer Inc. | — | $1.7M | 404.30% |
| Eli Lilly and Company | — | $1.4M | 333.38% |
| Merck and Co. Inc. | — | $1.3M | 317.53% |
| Thermo Fisher Scientific Inc. | — | $1.3M | 316.21% |
| AbbVie Inc. | — | $1.3M | 300.90% |
| Bristol-Myers Squibb Company | — | $1.1M | 270.79% |
| Abbott Laboratories | — | $1.0M | 244.71% |
| Danaher Corporation | — | $996K | 237.92% |
| Gilead Sciences Inc. | — | $861K | 205.72% |
| CVS Health Corporation | — | $793K | 189.34% |
| Cigna Corporation | — | $765K | 182.67% |
| Elevance Health Inc. | — | $737K | 175.97% |
| Amgen Inc. | — | $736K | 175.93% |
| Report date | Net assets |
|---|---|
| 2022-07-31 | $41.9M |
| 2022-04-30 | $41.0M |
| 2022-01-31 | $42.0M |
| 2021-10-31 | $52.1M |
| 2021-07-31 | $53.8M |
| 2021-04-30 | $52.0M |
| 2021-01-31 | $48.9M |
| 2020-10-31 | $43.3M |